RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
+21.75%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.87B
AUM Growth
+$3.87B
Cap. Flow
+$152M
Cap. Flow %
3.92%
Top 10 Hldgs %
35.18%
Holding
134
New
3
Increased
60
Reduced
11
Closed
5

Top Buys

1
IMCR icon
Immunocore
IMCR
$38.6M
2
BPMC
Blueprint Medicines
BPMC
$36.8M
3
AKRO icon
Akero Therapeutics
AKRO
$23.5M
4
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$20.7M
5
GOSS icon
Gossamer Bio
GOSS
$19M

Top Sells

1
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
$64.6M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$20.5M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
$16.8M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
$16.1M
5
EPZM
Epizyme, Inc
EPZM
$11M

Sector Composition

1 Healthcare 96.8%
2 Consumer Staples 0.91%
3 Industrials 0.67%
4 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LPTX icon
101
Leap Therapeutics
LPTX
$12M
$3.22M 0.08%
3,659,847
+6,900
+0.2% +$6.07K
FULC icon
102
Fulcrum Therapeutics
FULC
$353M
$3.11M 0.08%
384,590
– –
BLSA
103
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$3.1M 0.08%
309,000
– –
ALT icon
104
Altimmune
ALT
$325M
$2.85M 0.07%
+223,255
New +$2.85M
THRX
105
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$2.54M 0.07%
437,329
– –
ADAP
106
Adaptimmune Therapeutics
ADAP
$13.9M
$2.53M 0.07%
2,357,544
– –
ICVX
107
DELISTED
Icosavax, Inc. Common Stock
ICVX
$2.47M 0.06%
781,000
+19,443
+3% +$61.4K
FATE icon
108
Fate Therapeutics
FATE
$115M
$2.47M 0.06%
110,000
– –
SPRB
109
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$2.22M 0.06%
1,622,689
– –
JYAC
110
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$2.06M 0.05%
206,200
– –
ELVN icon
111
Enliven Therapeutics
ELVN
$1.24B
$1.92M 0.05%
842,402
– –
SYRE icon
112
Spyre Therapeutics
SYRE
$1.02B
$1.8M 0.05%
3,413,906
+341,872
+11% +$180K
SPRO icon
113
Spero Therapeutics
SPRO
$117M
$1.54M 0.04%
770,710
– –
VINC
114
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$1.53M 0.04%
1,108,570
+294,376
+36% +$406K
TPST icon
115
Tempest Therapeutics
TPST
$46.6M
$1.43M 0.04%
823,654
– –
TLPH icon
116
Talphera
TLPH
$11.2M
$1.32M 0.03%
6,329,202
– –
BHVN icon
117
Biohaven
BHVN
$1.71B
$1.06M 0.03%
+167,421
New +$1.06M
EPIX icon
118
ESSA Pharma
EPIX
$11.2M
$955K 0.02%
524,944
– –
CGEN icon
119
Compugen
CGEN
$133M
$848K 0.02%
1,289,990
– –
BCEL
120
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$726K 0.02%
462,530
– –
APLT icon
121
Applied Therapeutics
APLT
$73.7M
$653K 0.02%
701,680
– –
PHAS
122
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$479K 0.01%
2,719,074
-55,795
-2% -$9.83K
NUVB.WS icon
123
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
$27K ﹤0.01%
134,028
– –
SRRA
124
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-1,174,786
Closed -$64.6M
EPZM
125
DELISTED
Epizyme, Inc
EPZM
– –
-7,485,543
Closed -$11M
2 3 4
5
6